• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

禁食和非禁食受试者对肠溶包衣及缓释制剂中茶碱的吸收情况。

Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.

作者信息

Osman M A, Patel R B, Irwin D S, Welling P G

出版信息

Biopharm Drug Dispos. 1983 Jan-Mar;4(1):63-72. doi: 10.1002/bdd.2510040109.

DOI:10.1002/bdd.2510040109
PMID:6839003
Abstract

The influence of prior food ingestion, and also of varying fluid volumes, on plasma theophylline levels was examined following single oral doses of two sustained-release formulations, Theobid (260 mg) and Theo-Dur (200 mg) and one partially enteric-coated formulation, Choledyl (128 mg), to 9 healthy volunteers. Prior food ingestion tended to delay the absorption of theophylline from all formulations to a small extent. This effect was observed only at early sampling times, and plasma drug profiles were similar for all treatments within a particular formulation. Theobid and Theo-Dur gave rise to plasma profiles that were characteristic of sustained-release formulations, with mean Cmax values of 5.5-5.7 micrograms ml-1 (Theobid) and 2.8-3.2 micrograms ml-1 (Theo-Dur) occurring at 5.8-9.1 h after dosing. Choledyl gave rise to a longer absorption lag time than the other formulations but was subsequently absorbed at a faster rate yielding mean Cmax values of 3.2-3.5 micrograms ml-1 at 2.8-4.1 h. The intersubject variability in theophylline plasma levels, and also in most pharmacokinetic parameter values, was generally less following Theo-Dur compared to the other formulations.

摘要

对9名健康志愿者单次口服两种缓释制剂(茶喘平(260毫克)和优喘平(200毫克))以及一种部分肠溶衣制剂(胆茶碱(128毫克))后,研究了先前摄入食物以及不同液体量对血浆茶碱水平的影响。先前摄入食物往往会在一定程度上略微延迟所有制剂中茶碱的吸收。这种影响仅在早期采样时间观察到,并且在特定制剂内所有治疗的血浆药物曲线相似。茶喘平和优喘平产生了具有缓释制剂特征的血浆曲线,给药后5.8 - 9.1小时的平均Cmax值为5.5 - 5.7微克/毫升(茶喘平)和2.8 - 3.2微克/毫升(优喘平)。胆茶碱的吸收滞后时间比其他制剂更长,但随后以更快的速度被吸收,在2.8 - 4.1小时产生的平均Cmax值为3.2 - 3.5微克/毫升。与其他制剂相比,优喘平给药后茶碱血浆水平以及大多数药代动力学参数值的受试者间变异性通常较小。

相似文献

1
Absorption of theophylline from enteric coated and sustained release formulations in fasted and non-fasted subjects.禁食和非禁食受试者对肠溶包衣及缓释制剂中茶碱的吸收情况。
Biopharm Drug Dispos. 1983 Jan-Mar;4(1):63-72. doi: 10.1002/bdd.2510040109.
2
Bioavailability of four slow-release theophylline formulations in the beagle dog.
J Vet Pharmacol Ther. 1986 Sep;9(3):293-302. doi: 10.1111/j.1365-2885.1986.tb00044.x.
3
Bioavailability and pharmacological effects of two slow-release theophylline preparations: intrasubject tablet-to-tablet variability.
J Asthma. 1986;23(3):113-22. doi: 10.3109/02770908609077485.
4
Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.每日一次和每日两次茶碱给药系统的药代动力学比较。
Clin Ther. 1994 Jul-Aug;16(4):686-92.
5
Theophylline absorption from two sustained-release products. Implications for therapeutic drug monitoring.两种缓释制剂中茶碱的吸收情况。对治疗药物监测的意义。
Am Rev Respir Dis. 1987 Nov;136(5):1168-73. doi: 10.1164/ajrccm/136.5.1168.
6
Evaluation of the absorption from some commercial enteric-release theophylline products.对一些市售肠溶型茶碱产品吸收情况的评估。
J Pharmacokinet Biopharm. 1980 Apr;8(2):151-64. doi: 10.1007/BF01065190.
7
The relation of product formulation to absorption of oral theophylline.产品配方与口服茶碱吸收的关系。
N Engl J Med. 1978 Oct 19;299(16):852-7. doi: 10.1056/NEJM197810192991603.
8
Absorption of theophylline from conventional and sustained-release tablets.
Int J Clin Pharmacol Ther Toxicol. 1981 Mar;19(3):131-8.
9
Absorption of sustained-release theophylline tablets.
Int J Clin Pharmacol Ther Toxicol. 1983 Jul;21(7):359-62.
10
Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
Eur J Clin Pharmacol. 1984;26(3):401-3. doi: 10.1007/BF00548775.

引用本文的文献

1
Interactions affecting drug absorption.影响药物吸收的相互作用。
Clin Pharmacokinet. 1984 Sep-Oct;9(5):404-34. doi: 10.2165/00003088-198409050-00002.
2
A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.缓释型茶碱产品选用的临床及药代动力学依据
Clin Pharmacokinet. 1984 Mar-Apr;9(2):95-135. doi: 10.2165/00003088-198409020-00001.
3
The influence of food on the bioavailability of a slow release theophylline preparation.食物对缓释型茶碱制剂生物利用度的影响。
Clin Pharmacokinet. 1987 Oct;13(4):267-72. doi: 10.2165/00003088-198713040-00004.
4
Effects of formulation and food on the absorption of hydrochlorothiazide and triamterene or amiloride from combination diuretic products.制剂和食物对复方利尿产品中氢氯噻嗪与氨苯蝶啶或阿米洛利吸收的影响。
Pharm Res. 1987 Aug;4(4):348-52. doi: 10.1023/a:1016409606936.
5
The effect of food on the absorption of controlled-release theophylline in mini-swine.食物对小型猪体内控释茶碱吸收的影响。
Pharm Res. 1988 Jan;5(1):48-52. doi: 10.1023/a:1015815528975.
6
Food interactions with sustained-release theophylline preparations. A review.食物与缓释茶碱制剂的相互作用。综述。
Clin Pharmacokinet. 1989 Mar;16(3):162-79. doi: 10.2165/00003088-198916030-00003.